Literature DB >> 9551377

Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995.

P J Barber1, J Elliott.   

Abstract

Eighty cats with chronic renal failure (CRF) were evaluated in a prospective study to investigate the prevalence and aetiopathogenesis of renal secondary hyperparathyroidism (RHPTH), using routine plasma biochemistry and assays of parathyroid hormone (PTH), blood ionised calcium and 1,25 dihydroxycholecalciferol (1,25[OH]2D3). Hyperparathyroidism was a frequent sequela of CRF, affecting 84 per cent of cats with CRF, the severity and prevalence of RHPTH increasing with the degree of renal dysfunction. Compared with an age-matched control population, plasma concentrations of phosphate and PTH were significantly higher and 1,25(OH)2D3 concentrations were significantly lower in the two groups of cats presenting with clinical signs of CRF. Significant ionised hypocalcaemia was present only in cats with end-stage renal failure. However, a number of cats were hyperparathyroid in the absence of abnormalities in the parameters of calcium homeostasis measured in this study. There was a significant correlation between plasma phosphate and PTH concentrations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551377     DOI: 10.1111/j.1748-5827.1998.tb03613.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  21 in total

1.  Pathology in Captive Wild Felids at German Zoological Gardens.

Authors:  Johannes Junginger; Florian Hansmann; Vanessa Herder; Annika Lehmbecker; Martin Peters; Martin Beyerbach; Peter Wohlsein; Wolfgang Baumgärtner
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

2.  Chronic Vitamin D Intoxication in Captive Iberian Lynx (Lynx pardinus).

Authors:  Ignacio Lopez; Carmen Pineda; Luis Muñoz; Ana Raya; Guillermo Lopez; Escolástico Aguilera-Tejero
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

3.  Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease.

Authors:  M K Tolbert; S Olin; S MacLane; E Gould; J M Steiner; S Vaden; J Price
Journal:  J Vet Intern Med       Date:  2017-08-20       Impact factor: 3.333

4.  Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia.

Authors:  D H N van den Broek; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2017-02-12       Impact factor: 3.333

5.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

6.  Factors associated with survival in dogs with chronic kidney disease.

Authors:  Adam J Rudinsky; Laura M Harjes; Julie Byron; Dennis J Chew; Ramiro E Toribio; Catherine Langston; Valerie J Parker
Journal:  J Vet Intern Med       Date:  2018-10-16       Impact factor: 3.333

Review 7.  Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

Authors:  Joao F de Brito Galvao; Larry A Nagode; Patricia A Schenck; Dennis J Chew
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2013 Mar-Apr

8.  Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Survival Time in Cats with Chronic Kidney Disease.

Authors:  R F Geddes; J Elliott; H M Syme
Journal:  J Vet Intern Med       Date:  2015-09-25       Impact factor: 3.333

9.  The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium-Phosphate Homeostasis in Healthy Older Cats.

Authors:  R F Geddes; V Biourge; Y Chang; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2016-08-16       Impact factor: 3.333

10.  ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Authors:  Stanley L Marks; Peter H Kook; Mark G Papich; M K Tolbert; Michael D Willard
Journal:  J Vet Intern Med       Date:  2018-10-31       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.